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The identification of immune response mechanisms that contribute to the control of diarrheal disease in
developing countries remains an important priority. We addressed the role of fecal chemokines and cytokines
in the resolution of diarrheal Escherichia coli and Giardia lamblia infections. Stools collected from 127 Mexican
children 5 to 15 months of age enrolled in a randomized, double-blind, placebo-controlled, vitamin A supple-
mentation trial were screened for enteropathogenic Escherichia coli (EPEC), enterotoxigenic E. coli (ETEC),
and Giardia lamblia. Fecal concentrations of tumor necrosis factor alpha (TNF-), monocyte chemoattractant
protein-1 (MCP-1), interleukin-4 (IL-4), IL-5, IL-6, IL-8, IL-10, and interferon- (IFN-) were determined.
Hazard models incorporating cytokine variables were fit to durations of asymptomatic and symptomatic
pathogen infections, controlling for treatment group. Increased levels of TNF- and IL-6 were associated with
decreased durations of EPEC infection and increased ETEC durations. Increased IL-4 and IFN- levels were
associated with decreased and increased durations, respectively, of both EPEC and ETEC infections. Increased
IL-10 levels were associated with increased and decreased durations of asymptomatic and symptomatic EPEC
infections, respectively, and increased durations of both asymptomatic and symptomatic ETEC infections.
Increased levels of MCP-1, IFN-, IL-4, and IL-5 were associated with increased G. lamblia infection duration,
while increased IL-8 levels were associated with decreased durations. Differences in proinflammatory and Treg
cytokine levels are associated with differences in the resolution of inflammatory and noninflammatory patho-
gen infections.
Pediatric diarrheal disease continues to be an important
health problem in developing countries, with the disability-
adjusted life year (DALY) for this disease estimated to be
approximately 100 million, 95% of which is due to mortality
(36). A broad range of gastrointestinal pathogens cause diar-
rhea among young children in these settings. Diarrheagenic
Escherichia coli pathotypes (DEPs) represent a leading bacte-
rial cause of diarrhea, with enteropathogenic E. coli (EPEC)
and enterotoxigenic E. coli (ETEC) representing the most
important pathogens of this group (7, 41). The disease burden
due to such gastrointestinal parasites as Giardia lamblia also
continues to be an important health problem in countries such
as Mexico (31).
We have addressed the efficacy of vitamin A supplementa-
tion in reducing the burden of pathogen-specific diarrhea by
carrying out a randomized, placebo-controlled, double-blind
trial among children living in peri-urban areas of Mexico City.
Supplementation in this trial was associated with pathogen-
specific effects on the fecal innate and adaptive cytokine re-
sponses and with divergent pathogen-specific clinical outcomes
(30, 32). We now want to understand how the effect of vitamin
A on these cytokine responses is associated with pathogen-
specific outcomes.
Recent research has reported that distinct cytokine path-
ways are involved in the host responses to each of these en-
teropathogens (12, 21). These findings suggest that a specific
cytokine response adequate for resolving one pathogen infec-
tion may be inappropriate against a different pathogen and so
lead to prolonged infection and pathogenesis. An important
first step in our overall analysis then is to determine how these
different cytokine response pathways are associated with spe-
cific pathogen infection outcomes. These findings subsequently
will allow us to determine how the modification of these re-
sponses by vitamin A changes these associations.
Accordingly, in this paper we examine whether distinct path-
ways in the gut are effective responses in resolving infections by
ETEC, EPEC, and G. lamblia. These pathogens were chosen
because each produces pathology through quite different
mechanisms and induce quite different cytokine responses.
EPEC expresses virulence factors that lead to the formation of
attaching and effacing (A/E) lesions in the mucosa and subse-
quent onset of diarrhea (7). ETEC, in contrast, expresses the
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heat-labile and heat-stable toxins and multiple adhesive pili
called colonization factors (CFs), which lead to the production
of watery diarrhea (41). Finally, G. lamblia produces inflam-
mation and villous atrophy after attaching to epithelial cell
surfaces and so reduces the gut’s absorptive capability (2).
These differences allowed us to address the hypothesis that the
distinct fecal cytokine profiles produced during infections by
each of these pathogens will be associated with differences in
pathogen infection duration.
MATERIALS AND METHODS
Study population and recruitment. A census was carried out of all children less
than 2 years of age living within nine neighborhoods (colonias) that are part of
the community of La Magdalena Atlicpac, which is located along the eastern
perimeter of Mexico City. Mothers of all children from 5 to 15 months of age
were invited to participate in the study as described previously (29, 32). Children
were excluded if they had diseases causing immunosuppression or any congenital
or acquired alteration of the digestive tract, such as chronic diarrhea, that could
alter the absorption of micronutrients. Children who were taking vitamin sup-
plements also were excluded. For the overall study, 200 children living in this
community were identified and enrolled during a 10-month period after their
parents consented to their participation.
Each child, once enrolled, was randomly assigned to receive vitamin A or a
placebo every 2 months. Recruited children then were monitored prospectively
for up to 15 months, during which time households were visited twice a week. At
each visit mothers or child caretakers were interviewed to determine the pres-
ence of the following symptoms: diarrhea, the number and consistency of evac-
uations, the presence of blood and mucus in stools, fever, cough, and respiratory
difficulty.
Sample collection and processing. A stool sample was collected twice a month
among healthy children, and up to three stools were collected in the week
following a diarrheal episode. Project supervisors accompanied approximately
5% of all household visits to ensure the quality of data collection. Children were
referred to the study physician for diagnosis and treatment when the fieldworker
or caregiver was concerned about the child’s health status.
Examination of stools for parasites and bacteria. All stool samples were
plated onto salmonella-shigella, MacConkey, and MacConkey-tellurite agars for
the identification of Salmonellae spp., Shigella spp., and E. coli (20). The Kato-
Katz technique and the trichrome staining of wet mounts of concentrated stool
were performed to identify Ascaris lumbricoides, Entamoeba histolytica, and G.
lamblia ova in stool (34). Three lactose-fermenting colonies with morphology
resembling that of E. coli (when present) were selected from MacConkey agar
plates and speciated biochemically. Diarrheagenic E. coli was characterized by a
single-multiplex technique, previously described (10), that detects the following
pathogenic genes: heat-stable and heat-labile enterotoxins (st and lt) for entero-
toxigenic E. coli (ETEC), intimin (eaeA) and bundle-forming pilus (bfp) for
enteropathogenic E. coli (EPEC), Shiga toxins 1 and 2 (stx1 and stx2) and intimin
(eaeA) for shiga toxin-producing E. coli (STEC), and invasive-associated loci
(ia1) for enteroinvasive E. coli (EIEC).
Analysis of stool cytokines by ELISA. An aliquot from each fresh stool col-
lected from children was frozen within 4 h after collection at 20°C. For this
study, we analyzed cytokines from a subsample of children during the summer
months of June, July, and August, since this period is when diarrheal E. coli is the
most prevalent and when diarrheal rates reach their peak. As such, samples were
extracted as described previously (29) and the supernatants were collected,
frozen, and stored at 70°C. These supernatants then were assayed for the
chemokines monocyte chemoattractant protein-1 (MCP-1) and interleukin-8
(IL-8), the proinflammatory cytokines tumor necrosis factor alpha (TNF-) and
IL-6, the Th1 cytokine gamma interferon (IFN-), the Th2 cytokines IL-4 and
IL-5, and the T-regulatory cytokine (Treg) IL-10 by an enzyme-linked immu-
nosorbent assay (ELISA) using paired ELISA-specific capture and biotinylated
detecting antibody (Ab) (Pierce-Endogen, Rockford, IL, and R&D Systems,
Minneapolis, MN). Peroxidases conjugated to streptavidin (Pierce-Endogen,
Rockford, IL) were used to detect the capture Ab, and peroxidase activity was
measured using 2,2-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) sub-
strate and read at a wavelength of 405 nm. Recombinant cytokines and chemo-
kines were used to generate a standard curve, and levels of these cytokines and
chemokines from the stool extracts were determined using the standard curve in
96-well plates according to the manufacturer’s protocol. The unit for all cytokine
assays was pg/ml normalized to mg/ml of protein per stool. The detection limit
for these cytokine assays was 10 pg/ml.
Statistical analysis. The primary end points for this analysis were the dura-
tions of infections by ETEC, EPEC, and G. lamblia in children during the
3-month summer months of June, July, and August. These pathogens were
selected for the analysis due to their importance as etiological agents in diarrhea
among Mexican children (32). Infections by ETEC were defined as any lactose-
positive bacteria isolated from stool that had the pathogenic genes for the
heat-stable and heat-labile enterotoxins (st and lt), while infections by EPEC
were defined by the absence of Shiga toxin genes and the presence of the genes
for intimin (eaeA) for both typical EPEC (tEPEC) and atypical EPEC and the
bundle-forming pilus (bfp) gene for tEPEC. An infection by G. lamblia was
defined as a stool positive for the parasite. Separate analyses were not carried out
for ETEC isolates that had only the st gene or the lt gene or for EPEC isolates
with only the eaeA gene due to the small number of these pathotypes during the
summer period. The beginning of an infection was defined as the midpoint in
time between a stool negative for a pathogen and a subsequent positive stool.
The end of the episode was defined as the midpoint between the last sequentially
positive stool and the subsequent negative stool. Durations of pathogen infec-
tions were defined as encompassing the time between these two midpoints.
The means and standard deviations of infection duration first were calculated
for each pathogen stratified by chemokine and cytokine values classified into
three levels: nondetectable, less than the median of positives, and greater than or
equal to the median of positives. These means were calculated separately for
asymptomatic and symptomatic infections. The classification into levels was
carried out because an important proportion of stool samples had no detectable
levels of cytokines. These samples would have had to be eliminated from any
analysis of durations if continuous variables for the chemokines and cytokines
were used.
Weibull parametric regression survival time models then were fit to the dura-
tions of pathogen infections stratified by these chemokine and cytokine levels to
test how differences in these levels were associated with durations. Children from
both the vitamin A and placebo groups were included in these analyses. A
variable indicating whether a child received the vitamin A supplement or a
placebo was included in each model to control for supplementation. Statistical
significance was set at a probability level of 0.05 and at 0.1 for interactions.
The analysis was carried out using the STREG procedure from STATA (version
9.0) software (StataCorp, College Station, TX).
Sample size calculations. Sample sizes were calculated based on the assump-
tion that the study population had a diarrheal disease rate of three episodes per
child per year and that the vitamin A supplement would reduce this rate by
approximately 20%. This effect approximated the reduction in diarrhea inci-
dence reported by Barreto et al. in their vitamin A trial in Brazil (3). It was
calculated that a sample size of 100 per group was required to detect a 20%
reduction between the control and treatment group with 80 and 95% significance
levels and an expected loss to follow-up of 20%. This calculation allowed for the
repeated measurements of the outcome and a correlation between measure-
ments at different time points of 0.7 (13).
The study was approved by the ethical review committees from the National
Centre for the Health of Infants and Adolescences of Mexico (CENSIA) and the
Harvard School of Public Health.
RESULTS
Number of enrolled children. Results from a subsample of
127 children monitored during the months of June, July, and
August are included in this analysis. The remaining 73 children
were not enrolled until the fall and were not included in the
analysis. A total of 505 stool samples were collected from these
127 children, 262 samples from 70 children administered the
placebo and 243 samples from 57 children administered the
vitamin A supplement.
Clinical history of study children. A total of 149 pathogen
isolates were identified in stools collected during the 3-month
period of this analysis, representing 131 separate episodes of
infection. ETEC infections were the most frequent (49), fol-
lowed by EPEC infections (46). Additionally, 30 Giardia epi-
sodes were identified, while the remaining infections were due
to Shiga toxin-producing E. coli (STEC), enteroinvasive E. coli
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(EIEC), A. lumbricoides, and E. histolytica. Ninety-four per-
cent of ETEC isolates (59/62) had only the lt heat-labile en-
terotoxin gene, while the remaining 3% had genes for both the
heat-labile and st heat-stable enterotoxins. Seventy-eight per-
cent of the EPEC isolates (43/59) were atypical, having only
the eaeA intimin gene, while the remaining 22% had both the
intimin and the bundle-form pilus gene (bfp). Eleven of 50
ETEC infections were associated with a diarrheal episode,
while 23 of 47 EPEC infections were associated with an epi-
sode.
Associations between fecal cytokine responses and EPEC
infection durations. Innate and adaptive cytokines were signif-
icantly associated with durations of EPEC, ETEC, and G.
lamblia infections, but the directions of these associations were
different for each pathogen and clinical outcome. Tables 1 and
2 present the hazard rates for durations of asymptomatic and
symptomatic EPEC infections (both eaeA and eaeA plus bfp
pathotypes) by cytokine levels. Asymptomatically infected chil-
dren with intermediate fecal levels of IL-6 or intermediate and
high fecal levels of TNF- have increased risks of an episode
ending, thus they have reduced durations of infection com-
pared to that of children with no detectable levels. For the
adaptive immune response, there is an increased risk of an
asymptomatic infection ending among children with high levels
of IL-4 and IL-5 in stool compared to that of children with no
detectable levels. In contrast, children with high fecal levels of
IFN- and IL-10 have reduced risks, thus they have increased
infection durations compared to those of children with no
detectable levels.
For symptomatic infections, children with intermediate fecal
levels of IL-6 and IL-8 have an increased risk of an episode
ending and reduced durations of infection compared to those
of children with no detectable levels. For the adaptive immune
response, an increased risk of an episode ending is found
among children with intermediate levels of IL-5. In contrast,
children with intermediate levels of IFN- have reduced risks,
thus they have increased infection durations compared to those
of children with no detectable levels. This contrasts with the
increased risk and reduced duration found among symptom-
atically infected children who have high levels of IL-10.
Associations between fecal cytokines and ETEC infection
durations. Tables 3 and 4 present the hazard rates for dura-
tions of asymptomatic and symptomatic ETEC infections (both
lt and st plus lt pathotypes) by cytokine levels. Children with
intermediate levels of TNF- in stool have a reduced risk that
an asymptomatic ETEC infection will end, thus they have
longer infection durations compared to those of children with
no detectable levels. Intermediate levels of IL-8 in children’s
stool, in contrast, are associated with an increased risk that an
asymptomatic infection will end, leading to a reduced infection
duration. Children with intermediate and high fecal levels of
IL-4 have a greater risk of an asymptomatic ETEC episode
TABLE 1. Parametric hazard regression analyses of the association between innate and adaptive immune response cytokine
levels and durations of asymptomatic EPEC infectionsa
Cytokine and
response
No. of
infections
Mean duration
( SD, in days) of
asymptomatic EPEC
infections
Risk of asymptomatic EPEC
infection ending
Hazards ratio
(95% CI) P
Innate immune
IL-6
ND 12 18.41  13.22 1.00
Median 3 14  30.12 15.7 (0.93–263.22) 0.05
Median 3 21.5  5.07 0.90 (0.18–40.49) 0.90
TNF-
ND 10 26.7  220.15 1.00
Median 5 19.3  150.00 12.78 (10.94–84.13) 0.01
Median 4 15.62  90.63 4.9 (0.77–310.25) 0.09
Adaptive immune
IFN- (Th1)
ND 14 19  120.45 1.00
Median 2 14.5  4.24 1.99 (0.42–90.31) 0.38
Median 4 37.12  30.82 0.21 (0.06–00.72) 0.01
IL-4 (Th2)
ND 13 25.30  21.15 1.00
Median 1 20.5 1.98 (0.20–19.63) 0.55
Median 6 15.66  70.54 7.55 (1.56–36.01) 0.01
IL-5 (Th2)
ND 12 26.75  21.79 1.00
Median 5 17.3  2.30 1.28 (0.33–40.96) 0.71
Median 3 12  70.46 6.62 (1.41–30.95) 0.01
IL-10
ND 10 16.7  11.05 1.00
Median 5 24.4  110.72 0.49 (0.16–10.46) 0.20
Median 4 34.25  33.95 0.17 (0.04–0.64) 0.01
a Hazard rates were calculated after fitting the Weibull hazard model to the length of infection duration. Infection duration was defined as the time from the first
positive stool until the first negative stool among sequentially collected stools. Reference groups are stool samples with no detectable levels of chemokine or cytokine.
CI, confidence interval.
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ending, thus they have reduced durations of infection com-
pared to those of children with no detectable levels. In con-
trast, children with high fecal levels of IFN- and IL-10 have
reduced risks, thus they have increased durations of asymp-
tomatic ETEC infections compared to those of children with
no detectable levels. For symptomatic ETEC infections, chil-
dren with high fecal levels of IL-6 and TNF- have greatly
reduced risks that an infection will end, thus they have in-
creased infection durations compared to those of children with
no detectable levels. Children with intermediate and high lev-
els of the adaptive IL-5 and IL-10 cytokines in stool also have
reduced risks of an episode ending. In contrast, children with
intermediate levels of IL-4 have an increased risk that a symp-
tomatic ETEC infection will end, thus they have a reduced
infection duration compared to that of children with no de-
tectable levels.
Associations between fecal cytokines and G. lamblia infec-
tion durations. Only two G. lamblia infections were symptom-
atic, so separate analyses of asymptomatic and symptomatic
durations were not carried out (Table 5). Children with inter-
mediate fecal levels of the chemokine IL-8 had a significantly
increased risk that G. lamblia infections would end, thus they
had reduced infection durations compared to those of children
with no detectable levels. In contrast, children with high levels
of MCP-1 had a significantly decreased risk that a G. lamblia
infection would end and thus significantly increased durations
relative to those of children with no detectable concentrations.
A significantly decreased risk of a G. lamblia infection ending
was found among children with the highest fecal concentra-
tions of IFN- and IL-4. Both intermediate and high levels of
IL-5 also were associated with significantly decreased risks of
G. lamblia infections ending, with intermediate levels being
associated with the greatest reductions.
DISCUSSION
We have found significant differences in associations be-
tween levels of innate and adaptive immune response cyto-
kines in stool and durations of asymptomatic and symptomatic
infections by EPEC, ETEC, and G. lamblia. The most impor-
tant differences were found between levels of the proinflam-
matory and regulatory cytokines and durations of asymptom-
atic and symptomatic DEP infections. These results suggest
that specific cytokine responses play different roles in resolving
specific pathogen infections among young children in a com-
munity setting.
The proinflammatory cytokines are strongly and positively
associated with the resolution of EPEC infections in our study.
The association between increased TNF- and IL-6 levels and
decreased durations of both asymptomatic and symptomatic
EPEC infection is consistent with the role these cytokines play
in eliminating infections by the related mouse pathogen
Citrobacter rodentium (8, 15, 25, 42, 44). These proinflamma-
tory cytokines, secreted by both enterocytes and local Peyer’s
patch lymphocytes, activate effector mechanisms at the epithe-
lium (23). TNF-, for example, may eliminate infections
through its ability to activate macrophages and so increase
their phagocytic activity. There still is no consensus on the
importance of IL-8 in resolving infections, since the upregula-
tion of IL-8 by the epithelium also can result in increased
TABLE 2. Parametric hazard regression analyses of the association between innate and adaptive immune response cytokine
levels and durations of symptomatic EPEC infectionsa
Cytokine and
response
No. of
infections
Mean duration
( SD, in days) of
symptomatic EPEC
infections
Risk of symptomatic EPEC
infection ending
Hazards ratio
(95% CI) P
Innate immune
IL-6
ND 8 18.68  8.48 1.00
Median 2 14  9.89 5.33 (0.89–31.85) 0.06
Median 3 20  9.53 0.88 (0.23–31.85) 0.85
IL-8
ND 9 23.44  20.28 1.00
Median 4 14.62  5.34 9.01 (1.83–44.35) 0.01
Median 5 20.7  6.16 3.49 (0.90–13.54) 0.07
Adaptive immune
IFN- (Th1)
ND 8 19.06  7.97 1.00
Median 6 20.75  25.27 0.06 (0.008–0.45) 0.01
Median 2 26.25  7.42 0.66 (0.18–2.36) 0.52
IL-5 (Th2)
ND 11 18.18  7.89 1.00
Median 2 14.5  9.19 5.32 (1.20–23.53) 0.02
Median 4 18.5  8.34 2.06 (0.61–6.9) 0.23
IL-10
ND 10 22.25  19.57 1.00
Median 1 13.50 1.28 (0.18–9.27) 0.80
Median 5 18.7  7.64 3.49 (0.95–12.87) 0.06
a Hazard rates were calculated after fitting the Weibull hazard model to the length of infection duration. Infection duration was defined as the time from the first
positive stool until the first negative stool among sequentially collected stools. Reference groups are stool samples with no detectable levels of chemokine or cytokine.
CI, confidence interval.
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inflammation and pathology following neutrophil infiltration
(24, 28, 43, 44). This inconsistency may reflect the innate im-
mune system’s ability to provide a protective response but also
produce negative consequences, including exacerbated tissue
destruction, following the hyperactivation of this system (28).
This possibility suggests that the proinflammatory cytokines
are elevated as a result of inflammation independently of any
role they play in infection resolution.
The results from our study suggest that the adaptive Th1,
Th2, and Treg cytokine responses have contrasting roles in
limiting EPEC infections. The findings that increased levels of
IL-4 may play a role in resolving EPEC infections while in-
creased levels of IFN- may increase infection durations is not
consistent with the role of a Th1 response in resolving infec-
tions (17, 18, 45). However, Maaser et al. (33) have shown that
B cells are of crucial importance for the eradication of C.
rodentium, since mice lacking B cells could not clear the bac-
teria or decrease the bacterial burden during an extended
period. This finding suggests that a strictly Th1 response is not
adequate by itself in resolving infections.
A novel finding of the study is that increased IL-10 levels are
associated with the prolongation and resolution of asymptom-
atic and symptomatic EPEC infections, respectively. IL-10 is
an antiinflammatory cytokine produced by many cell types (4,
35, 38, 39). It acts principally to limit the damaging effects of
the inflammatory response to pathogen infections largely
through the inhibition of macrophage and dendritic cell func-
tion (9). However, high or dysregulated levels of IL-10 may
result in chronic infection (14, 47). The association between
high levels of IL-10 and the prolongation of asymptomatic
EPEC infections in our study may reflect the negative effect of
dysregulated IL-10 production on the clearance of EPEC in-
fections.
For ETEC, the association of increased levels of TNF-,
IL-6, and IFN- with increased durations suggests that these
components of the inflammatory responses are inadequate for
resolving ETEC infections. In contrast, increased IL-8 levels
appear to play an important role in infection resolution in our
study. A number of studies have reported similar contrasting
effects of ETEC infections on the expression of these cyto-
kines. For example, experimental vaccines expressing ETEC
fimbriae suppressed levels of TNF-, IL-1, and IL-6 (22, 40),
while in vitro and in vivo studies have reported that IL-8 levels
are significantly increased following ETEC infections (16, 19).
However, these studies do not indicate how the increased ex-
pression of these innate immune response cytokines relates to
the resolution of ETEC infection. It is important to consider
whether these cytokine levels could be elevated as a result of
inflammation independently of any role they play in infection
resolution.
The significant association between increased fecal IL-4 lev-
els and decreased ETEC infection durations is consistent with
the protective role of an upregulated Th2 cytokine response
against ETEC infections (5, 6, 37). An anti-enterotoxin (anti-
LT) intestinal IgA response upregulated by Th2 cytokines is
important in resolving ETEC infection and so may be mediat-
ing this association (11). High levels of IL-10 in our study
appear to be inadequate in resolving ETEC infections. This
result is consistent with findings that LT-ETEC-infected indi-
viduals with IL-10 alleles associated with high IL-10 produc-
TABLE 3. Parametric hazard regression analyses of the association between innate and adaptive immune response cytokine levels and
durations of asymptomatic ETEC infectionsa
Cytokine and
response
No. of
infections
Mean duration
( SD, in days) of
asymptomatic ETEC
infections
Risk of asymptomatic ETEC
infection ending
Hazards ratio
(95% CI) P
Innate immune
TNF-
ND 17 15.32  70.79 1.00
Median 6 27.58  12.76 0.29 (0.10–0.78) 0.01
Median 7 21.28  11.66 0.45 (0.17–10.19) 0.11
IL-8
ND 21 19.57  10.79 1.00
Median 6 14.75  50.13 5.90 (1.20–28.92) 0.03
Median 10 19.9  100.65 1.89 (0.68–28.92) 0.21
Adaptive immune
IFN- (Th1)
ND 14 14.96  90.75 1.00
Median 10 25.65  90.85 0.34 (0.14–0.84) 0.02
Median 9 18.83  90.50 0.61 (0.25–10.49) 0.28
IL-4 (Th2)
ND 21 22.09  11.90 1.00
Median 7 17.78  40.91 2.85 (0.86–90.36) 0.08
Median 8 13.81  70.00 3.50 (0.91–13.37) 0.06
IL-10
ND 13 15.92  80.19 1.00
Median 12 23.41  12.23 0.42 (0.18–0.98) 0.04
Median 7 19.07  10.57 0.65 (0.25–1.67) 0.37
a Hazard rates were calculated after fitting the Weibull hazard model to the length of infection duration. Infection duration was defined as the time from the first
positive stool until the first negative stool among sequentially collected stools. Reference groups are stool samples with no detectable levels of chemokine or cytokine.
CI, confidence interval.
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tion had a limited ability to rapidly clear infection (12). These
findings suggest that the antiinflammatory effects of high levels
of IL-10 inhibit the clearance of ETEC infections.
The increased durations of G. lamblia infections found
among children with increased fecal IFN-, IL-4, and IL-5
levels in our study is not consistent with reports that these
cytokines are elevated during the acute and elimination phases
of infection (1). Overall, T-cell-dependent mechanisms are
important in resolving acute G. lamblia infections (46). Intes-
tinal IgA antibodies, which are upregulated by Th2 cytokines,
are important in eradicating G. muris or G. lamblia infection
(27). However, a strong Th1 response also is important in
reducing G. lamblia intestinal trophozoites and fecal cyst
counts (48, 49). The reduced durations of G. lamblia infections
found among children with increased fecal IL-8 concentrations
also is not consistent with reports that the infection of mono-
layers of human colon epithelial cells did not lead to the in-
creased production of IL-8 or other chemokine or proinflam-
matory cytokine responses (23).
Overall, the clearest differences in associations between cy-
tokine levels and pathogen infection durations in our study
may relate to whether the pathogen induces a strong inflam-
matory response. Increased levels of the proinflammatory cy-
tokines are associated with the more rapid resolution of infec-
tions by EPEC, which induces a strong inflammatory response,
but reduced resolution of ETEC and G. lamblia infections,
which do not. Interestingly, no similar contrasting associations
are found for Th1 and Th2 cytokines for any of these three
pathogens. Another important difference is the association be-
tween IL-10 levels and the resolution of EPEC asymptomatic
and symptomatic infections. This finding may reflect the role
IL-10 plays in counterbalancing the inflammatory response,
which may be stronger in symptomatic than asymptomatic in-
fections. As a result, increased levels of IL-10 may be more
important in resolving symptomatic infections where the proin-
flammatory cytokines are overexpressed and causing tissue
damage.
These associations may not represent the development of a
protective immune response in the gut. The results for the
diarrheal E. coli pathotypes may reflect the ability of these
pathogens to actively downregulate a protective immune re-
sponse as part of a strategy of immune response evasion. Vir-
ulence factors such as intimin, EspA, and lymphostatin pro-
duced by EPEC can modify the expression of a wide range of
cytokines that effectively resolve infections (24, 26, 42, 44). As
a result, it is not clear whether increases in cytokine expression
during infection represent the development of a protective
response that leads to the resolution of infection or the devel-
opment of an inadequate response that can lead to prolonged
infection. Our use of parametric hazard models to analyze
infection durations is able to distinguish between these two
outcomes and may provide insight into inconsistencies between
different studies.
It is important to address a number of limitations of this
study. First, biases may have been introduced into the analysis
as a result of cytokine degradation. However, the treatment of
all samples during collection, processing, storage, and analysis
was identical, suggesting that such systematic bias was mini-
mized. Additionally, the inclusion of children from the placebo
and vitamin A groups in the analysis may have biased the
TABLE 4. Parametric hazard regression analyses of the association between innate and adaptive immune response cytokine levels and
durations of symptomatic ETEC infectionsa
Cytokine and
response
No. of
infections
Mean duration
( SD, in days) of
symptomatic ETEC
infections
Risk of symptomatic ETEC
infection ending
Hazards ratio
(95% CI) P
Innate immune
IL-6
ND 2 17.25  6.01 1.00
Median 2 19.75  1.76 0.06 (0.002–2.08) 0.12
Median 3 25  8.54 0.07 (0.005–1.01) 0.05
TNF-
ND 4 16.25  4.51 1.00
Median 1 16.00 0.14 (0.009–2.37) 0.17
Median 3 26.66  6.02 0.01 (0.000–0.24) 0.00
Adaptive immune
IL-4 (Th2)
ND 4 19.75  5.45 1.00
Median 3 16.33  4.50 11.04 (1.39–88.26) 0.02
Median 1 33.00 0.22 (0.026–2.00) 0.18
IL-5 (Th2)
ND 6 17  4.01 1.00
Median
Median 2 29.5  4.94 0.12 (0.02–0.72) 0.02
IL-10
ND 6 17  4.01 1.00
Median
Median 2 29.5  4.94 0.08 (0.009–0.80) 0.03
a Hazard rates were calculated after fitting the Weibull hazard model to the length of infection duration. Infection duration was defined as the time from the first
positive stool until the first negative stool among sequentially collected stools. Reference groups are stool samples with no detectable levels of chemokine or cytokine.
CI, confidence interval.
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results, given the effect vitamin A has on the immune response
(29). This potential bias has been controlled effectively through
the inclusion of a variable indicating whether the child was in
the vitamin A or placebo group.
Overall, we have found that different fecal cytokine profiles
are indeed associated with differences in pathogen infection
duration. If these findings can be confirmed, they have impor-
tant implications for the design of more effective vaccines that
take into account those cytokines that are important in limiting
infection and those that are inadequate. These results also can
be used in the development of more cost-effective public health
interventions. For example, they have important implications
for the design of vitamin A supplementation programs, since
the results suggest that communities that differ in indicators of
pathogen prevalence and diarrheal disease burden should be
targeted for interventions that differ in frequency, timing, and
dosage of supplementation.
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